NANOVIRICIDES, INC

Mar 26, 2019

NanoViricides has Requested a Pre-IND Meeting with the US FDA

Mar 05, 2019

NanoViricides Reports Excellent Safety Profile of Its First Drug Candidate in Dermal Treatment Study

Feb 26, 2019

NanoViricides Reaches an Agreement on Terms of License for Shingles Virus Drug Development

Feb 19, 2019

NanoViricides Files Quarterly Report for Period Ending December 31, 2018 - HerpeCide Drug Candidate Progressing in IND-Enabling Studies Towards Clinical Trials

Nov 26, 2018

NanoViricides Files Quarterly Report for Period Ending September 30, 2018

Jul 12, 2018

NanoViricides Provides Update on Recent Events

Jun 26, 2018

Progress of NanoViricides' Shingles Drug Program Presented at the 31st International Conference on Antiviral Research

May 22, 2018

NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and It Is Scaling Up Production of Certain Herpecide Program Drug Candidates